Chemical Formula: C13H16N2O2

Chemical Formula C13H16N2O2

Found 74 metabolite its formula value is C13H16N2O2

Melatonin

N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide

C13H16N2O2 (232.1211716)


Melatonin is a member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans. It has a role as a hormone, an anticonvulsant, an immunological adjuvant, a radical scavenger, a central nervous system depressant, a human metabolite, a mouse metabolite and a geroprotector. It is a member of acetamides and a member of tryptamines. It is functionally related to a tryptamine. Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and lowering the body temperature. Melatonin is also implicated in the regulation of mood, learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant. Most of the actions of melatonin are mediated through the binding and activation of melatonin receptors. Individuals with autism spectrum disorders (ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis. Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers. Melatonin is a hormone produced by the pineal gland that has multiple effects including somnolence, and is believed to play a role in regulation of the sleep-wake cycle. Melatonin is available over-the-counter and is reported to have beneficial effects on wellbeing and sleep. Melatonin has not been implicated in causing serum enzyme elevations or clinically apparent liver injury. Melatonin is a natural product found in Mesocricetus auratus, Ophiopogon japonicus, and other organisms with data available. Therapeutic Melatonin is a therapeutic chemically synthesized form of the pineal indole melatonin with antioxidant properties. The pineal synthesis and secretion of melatonin, a serotonin-derived neurohormone, is dependent on beta-adrenergic receptor function. Melatonin is involved in numerous biological functions including circadian rhythm, sleep, the stress response, aging, and immunity. Melatonin is a hormone involved in sleep regulatory activity, and a tryptophan-derived neurotransmitter, which inhibits the synthesis and secretion of other neurotransmitters such as dopamine and GABA. Melatonin is synthesized from serotonin intermediate in the pineal gland and the retina where the enzyme 5-hydroxyindole-O-methyltransferase, that catalyzes the last step of synthesis, is found. This hormone binds to and activates melatonin receptors and is involved in regulating the sleep and wake cycles. In addition, melatonin possesses antioxidative and immunoregulatory properties via regulating other neurotransmitters. Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is l... Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and. lowering the body temperature. Melatonin is also implicated in the regulation of mood,learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant. Most of the actions of melatonin are mediated through the binding and activation of melatonin receptors. Individuals with autism spectrum disorders(ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits. were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis. Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers. Melatonin, also known chemically as N-acetyl-5-methoxytryptamine, is a naturally occurring compound found in animals, plants and microbes. In animals, circulating levels of the hormone melatonin vary in a daily cycle, thereby allowing the entrainment of the circadian rhythms of several biological functions. A member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans. Melatonin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=73-31-4 (retrieved 2024-07-01) (CAS RN: 73-31-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5]. Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5].

   

Aminoglutethimide

3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine

C13H16N2O2 (232.1211716)


An aromatase inhibitor that produces a state of medical adrenalectomy by blocking the production of adrenal steroids. It also blocks the conversion of androgens to estrogens. Aminoglutethimide has been used in the treatment of advanced breast and prostate cancer. It was formerly used for its weak anticonvulsant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p454) CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3385; ORIGINAL_PRECURSOR_SCAN_NO 3383 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7127; ORIGINAL_PRECURSOR_SCAN_NO 7125 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7145; ORIGINAL_PRECURSOR_SCAN_NO 7141 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3404; ORIGINAL_PRECURSOR_SCAN_NO 3402 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3400; ORIGINAL_PRECURSOR_SCAN_NO 3398 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7086; ORIGINAL_PRECURSOR_SCAN_NO 7084 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7154; ORIGINAL_PRECURSOR_SCAN_NO 7153 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387; ORIGINAL_PRECURSOR_SCAN_NO 3385 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3391; ORIGINAL_PRECURSOR_SCAN_NO 3387 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7094; ORIGINAL_PRECURSOR_SCAN_NO 7091 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3376; ORIGINAL_PRECURSOR_SCAN_NO 3375 CONFIDENCE standard compound; INTERNAL_ID 1173; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7142; ORIGINAL_PRECURSOR_SCAN_NO 7138 L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents

   

(2E)-2-[[(Z)-3-Phenylbut-2-enyl]hydrazinylidene]propanoic acid

(2E)-2-[[(Z)-3-Phenylbut-2-enyl]hydrazinylidene]propanoic acid

C13H16N2O2 (232.1211716)


   

N-[2-(5-Methoxy-3H-indol-3-yl)ethyl]acetamide

N-[2-(5-Methoxy-3H-indol-3-yl)ethyl]acetamide

C13H16N2O2 (232.1211716)


   

Ethyl L-tryptophanate

Tryptophan ethyl ester, alpha-14C-labeled CPD (DL)-isomer

C13H16N2O2 (232.1211716)


   

Mofebutazone

4-butyl-3-hydroxy-1-phenyl-4,5-dihydro-1H-pyrazol-5-one

C13H16N2O2 (232.1211716)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

Pirmagrel

6-{imidazo[1,5-a]pyridin-5-yl}hexanoic acid

C13H16N2O2 (232.1211716)


   

N-acetylcytisine

N-acetylcytisine

C13H16N2O2 (232.1211716)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.452 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.447

   

5-Methoxy-1-methylspiro[indoline-3,3-pyrrolidin]-2-one

5-Methoxy-1-methylspiro[indoline-3,3-pyrrolidin]-2-one

C13H16N2O2 (232.1211716)


   

Melatonin

N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide

C13H16N2O2 (232.1211716)


N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CH - Melatonin receptor agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone D020011 - Protective Agents > D000975 - Antioxidants C26170 - Protective Agent > C275 - Antioxidant Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS ORIGINAL_PRECURSOR_SCAN_NO 3385; CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387; ORIGINAL_PRECURSOR_SCAN_NO 3385 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3400; ORIGINAL_PRECURSOR_SCAN_NO 3398 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3376; ORIGINAL_PRECURSOR_SCAN_NO 3375 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3184; ORIGINAL_PRECURSOR_SCAN_NO 3183 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3391; ORIGINAL_PRECURSOR_SCAN_NO 3387 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3198; ORIGINAL_PRECURSOR_SCAN_NO 3196 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7086; ORIGINAL_PRECURSOR_SCAN_NO 7084 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7064; ORIGINAL_PRECURSOR_SCAN_NO 7062 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7062; ORIGINAL_PRECURSOR_SCAN_NO 7059 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7093; ORIGINAL_PRECURSOR_SCAN_NO 7090 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7098; ORIGINAL_PRECURSOR_SCAN_NO 7096 CONFIDENCE standard compound; INTERNAL_ID 961; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7084; ORIGINAL_PRECURSOR_SCAN_NO 7082 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.685 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.686 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.679 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.682 Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5]. Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5].

   

n-acetyl-o-methylserotonin

n-acetyl-o-methylserotonin

C13H16N2O2 (232.1211716)


   
   
   

L-Tryptophan, N-methyl-, methyl ester

L-Tryptophan, N-methyl-, methyl ester

C13H16N2O2 (232.1211716)


   
   
   

N-dimethyl-l-tryptophan

N-dimethyl-l-tryptophan

C13H16N2O2 (232.1211716)


   

aminoglutethimide

Aminoglutethimide (Cytadren)

C13H16N2O2 (232.1211716)


L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents

   

3-Dimethylaminoacetyl-5-methoxyindole

3-Dimethylaminoacetyl-5-methoxyindole

C13H16N2O2 (232.1211716)


Origin: Plant; SubCategory_DNP: Alkaloids derived from tryptophan, Simple tryptamine alkaloids, Indole alkaloids

   

Tryptophan ethyl ester

Tryptophan ethyl ester

C13H16N2O2 (232.1211716)


   

ETHYL 5-[3-(DIMETHYLAMINO)PROP-1-YNYL]NICOTINATE

ETHYL 5-[3-(DIMETHYLAMINO)PROP-1-YNYL]NICOTINATE

C13H16N2O2 (232.1211716)


   

(R)-1-Methylmephenytoin

(R)-1-Methylmephenytoin

C13H16N2O2 (232.1211716)


   

4,6(1H,5H)-Pyrimidinedione,5-ethyldihydro-5-(4-methylphenyl)-

4,6(1H,5H)-Pyrimidinedione,5-ethyldihydro-5-(4-methylphenyl)-

C13H16N2O2 (232.1211716)


   

1-ETHYL-2-METHYL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

1-ETHYL-2-METHYL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

C13H16N2O2 (232.1211716)


   

(1H-IMIDAZOL-4-YL)-P-TOLYL-METHANONE

(1H-IMIDAZOL-4-YL)-P-TOLYL-METHANONE

C13H16N2O2 (232.1211716)


   

N-(3-(3-Hydroxyprop-1-ynyl)pyridin-2-yl)pivalamide

N-(3-(3-Hydroxyprop-1-ynyl)pyridin-2-yl)pivalamide

C13H16N2O2 (232.1211716)


   
   

METHYL 1-(TERT-BUTYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE

METHYL 1-(TERT-BUTYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE

C13H16N2O2 (232.1211716)


   

Methyl 1-tert-butyl-1H-benzo[d]imidazole-6-carboxylate

Methyl 1-tert-butyl-1H-benzo[d]imidazole-6-carboxylate

C13H16N2O2 (232.1211716)


   

N-CBZ-2,5-DIAZABICYCLO[2.2.1]HEPTANE

N-CBZ-2,5-DIAZABICYCLO[2.2.1]HEPTANE

C13H16N2O2 (232.1211716)


   

(S)-aminoglutethimide

(-)-Aminoglutethimide

C13H16N2O2 (232.1211716)


   

2-(2-morpholin-4-ylethoxy)benzonitrile

2-(2-morpholin-4-ylethoxy)benzonitrile

C13H16N2O2 (232.1211716)


   

(S,S)-(+)-PSEUDOEPHEDRINEGLYCINAMIDE

(S,S)-(+)-PSEUDOEPHEDRINEGLYCINAMIDE

C13H16N2O2 (232.1211716)


   
   

TERT-BUTYL 5-METHYL-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE

TERT-BUTYL 5-METHYL-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE

C13H16N2O2 (232.1211716)


   

Methyl 4-methyl-2-propyl-1H-benzimidazole-6-carboxylate

Methyl 4-methyl-2-propyl-1H-benzimidazole-6-carboxylate

C13H16N2O2 (232.1211716)


   

N-(1-CARBAMOYL-CYCLOPENTYL)-BENZAMIDE

N-(1-CARBAMOYL-CYCLOPENTYL)-BENZAMIDE

C13H16N2O2 (232.1211716)


   

(CHLOROMETHYL)VINYLBENZENE

(CHLOROMETHYL)VINYLBENZENE

C13H16N2O2 (232.1211716)


   

D-Aminoglutethimide

(R)-aminoglutethimide

C13H16N2O2 (232.1211716)


   

1-BENZYL-3(R)-ETHYL-PIPERAZINE-2,5-DIONE

1-BENZYL-3(R)-ETHYL-PIPERAZINE-2,5-DIONE

C13H16N2O2 (232.1211716)


   

1-BENZYL-3-ETHYL-PIPERAZINE-2,5-DIONE

1-BENZYL-3-ETHYL-PIPERAZINE-2,5-DIONE

C13H16N2O2 (232.1211716)


   

TERT-BUTYL 1H-INDOL-5-YLCARBAMATE

TERT-BUTYL 1H-INDOL-5-YLCARBAMATE

C13H16N2O2 (232.1211716)


   

tert-butyl 4-cyanobenzylcarbamate

tert-butyl 4-cyanobenzylcarbamate

C13H16N2O2 (232.1211716)


   

tert-Butyl 1H-indol-4-ylcarbamate

tert-Butyl 1H-indol-4-ylcarbamate

C13H16N2O2 (232.1211716)


   

tert-butyl N-[(S)-cyano(phenyl)methyl]carbamate

tert-butyl N-[(S)-cyano(phenyl)methyl]carbamate

C13H16N2O2 (232.1211716)


   

(6,7-DIMETHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLIN-1-YL)-ACETONITRILE

(6,7-DIMETHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLIN-1-YL)-ACETONITRILE

C13H16N2O2 (232.1211716)


   

(S)-N-Cbz-Valinenitrile

(S)-N-Cbz-Valinenitrile

C13H16N2O2 (232.1211716)


   

2-(4-Methoxyphenyl)-2,5-diazaspiro[3.4]octan-1-one

2-(4-Methoxyphenyl)-2,5-diazaspiro[3.4]octan-1-one

C13H16N2O2 (232.1211716)


   

3-(4-Ethoxyphenyl)-1,4-dimethyl-1H-pyrazol-5-ol

3-(4-Ethoxyphenyl)-1,4-dimethyl-1H-pyrazol-5-ol

C13H16N2O2 (232.1211716)


   

phenyl-7-amino-5-azaspiro[2.4]heptane-5-carboxylate

phenyl-7-amino-5-azaspiro[2.4]heptane-5-carboxylate

C13H16N2O2 (232.1211716)


   

4-(2-morpholin-4-ylethoxy)benzonitrile

4-(2-morpholin-4-ylethoxy)benzonitrile

C13H16N2O2 (232.1211716)


   

4,6(1H,5H)-Pyrimidinedione,dihydro-5-phenyl-5-propyl-

4,6(1H,5H)-Pyrimidinedione,dihydro-5-phenyl-5-propyl-

C13H16N2O2 (232.1211716)


   

2-tert-butyl-1-methyl-5-nitroindole

2-tert-butyl-1-methyl-5-nitroindole

C13H16N2O2 (232.1211716)


   

ethyl 2-amino-3-(1H-indol-2-yl)propanoate

ethyl 2-amino-3-(1H-indol-2-yl)propanoate

C13H16N2O2 (232.1211716)


   

(S)-1-BENZYL-3-ETHYLPIPERAZINE-2,5-DIONE

(S)-1-BENZYL-3-ETHYLPIPERAZINE-2,5-DIONE

C13H16N2O2 (232.1211716)


   

3-CBZ-3,6-DIAZABICYCLO[3.2.0]HEPTANE

3-CBZ-3,6-DIAZABICYCLO[3.2.0]HEPTANE

C13H16N2O2 (232.1211716)


   

3-(2-morpholin-4-ylethoxy)benzonitrile

3-(2-morpholin-4-ylethoxy)benzonitrile

C13H16N2O2 (232.1211716)


   

Pirmagrel

Pirmagrel

C13H16N2O2 (232.1211716)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D004791 - Enzyme Inhibitors

   

N-[3-(3-DIMETHYLAMINO-1-OXO-2-PROPENYL)PHENYL]ACETAMIDE

N-[3-(3-DIMETHYLAMINO-1-OXO-2-PROPENYL)PHENYL]ACETAMIDE

C13H16N2O2 (232.1211716)


   

α-Methyl-D,L-tryptophan Methyl Ester

α-Methyl-D,L-tryptophan Methyl Ester

C13H16N2O2 (232.1211716)


   
   

4-(2-Amino-4-cyano-phenyl)-butyric acid ethyl ester

4-(2-Amino-4-cyano-phenyl)-butyric acid ethyl ester

C13H16N2O2 (232.1211716)


   

ETHYL 5,6-DIMETHYL-1H-BENZIMIDAZOL-1-YL)ACETATE

ETHYL 5,6-DIMETHYL-1H-BENZIMIDAZOL-1-YL)ACETATE

C13H16N2O2 (232.1211716)


   

N-cyanoethyl-N-acetoxyethyl aniline

N-cyanoethyl-N-acetoxyethyl aniline

C13H16N2O2 (232.1211716)


   
   

1-piperidin-4-yl-4H-3,1-benzoxazin-2-one

1-piperidin-4-yl-4H-3,1-benzoxazin-2-one

C13H16N2O2 (232.1211716)


   

Tasipimidine

Tasipimidine

C13H16N2O2 (232.1211716)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

2-(2-Cyclohexylidenehydrazinyl)benzoic acid

2-(2-Cyclohexylidenehydrazinyl)benzoic acid

C13H16N2O2 (232.1211716)


   

Ethyl L-tryptophanate

Ethyl L-tryptophanate

C13H16N2O2 (232.1211716)


   

2-(dimethylamino)-1-(5-methoxy-1H-indol-3-yl)ethanone

2-(dimethylamino)-1-(5-methoxy-1H-indol-3-yl)ethanone

C13H16N2O2 (232.1211716)


   

Mofebutazone

Mofebutazone

C13H16N2O2 (232.1211716)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

5-[(4-Hydroxyphenyl)methyl]-3-imino-4,4-dimethylpyrrolidin-2-one

5-[(4-Hydroxyphenyl)methyl]-3-imino-4,4-dimethylpyrrolidin-2-one

C13H16N2O2 (232.1211716)


   

(2E)-2-[[(E)-3-phenylbut-2-enyl]hydrazinylidene]propanoic acid

(2E)-2-[[(E)-3-phenylbut-2-enyl]hydrazinylidene]propanoic acid

C13H16N2O2 (232.1211716)


   

N-(4-methylphenyl)carbamic acid (cyclopentylideneamino) ester

N-(4-methylphenyl)carbamic acid (cyclopentylideneamino) ester

C13H16N2O2 (232.1211716)